AUTHOR=Hall Mila , Scherner Paloma V. , Kreidel Yannic , Rubel Julian A.
TITLE=A Systematic Review of Momentary Assessment Designs for Mood and Anxiety Symptoms
JOURNAL=Frontiers in Psychology
VOLUME=12
YEAR=2021
URL=https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.642044
DOI=10.3389/fpsyg.2021.642044
ISSN=1664-1078
ABSTRACT=Background: Altering components of ecological momentary assessment (EMA) measures to better suit the purposes of individual studies is a common and oftentimes necessary step. Though the inherent flexibility in EMA has its benefits, no resource exists to provide an overview of the variability in how convergent constructs and symptoms have been assessed in the past. The present study fills that gap by examining EMA measurement design for mood and anxiety symptomatology.
Methods: Various search engines were used to identify 234 relevant studies. Items administered, data collection schedules (i.e., beeps per day), response scales (i.e., Likert), data collection platforms (i.e., apps), and psychometric properties (i.e., reliability) were extracted.
Results: Study designs varied greatly in all aspects across the identified papers. Over 4,600 extracted items were qualitatively analyzed, resulting in the identification of 12 themes. The most EMA items focused on affect, with categories such as “happiness” and “tension” appearing most frequently. We provide all of our data extraction in the format of an open-source database.
Limitations: Despite our best attempts to include as much of the relevant literature as possible, this review and the accompanying database are not exhaustive, but can easily be built upon to include other, newer studies.
Conclusions: The fact that the affect theme featured both positive and negative emotional constructs highlights the dichotomous focus on valence and affect within the literature surrounding anxious and depressive symptomatology. We hope that our database will act as a helpful design decision-making resource for researchers studying this kind of symptomatology in the future.
Systematic Review Registration: PROSPERO (CRD42019139409).